Wells Fargo raised the firm’s price target on Merit Medical to $85 from $81 and keeps an Equal Weight rating on the shares. Merit Medical’s top and bottom line both beat expectations, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MMSI:
- Merit Medical Systems Unveils Growth Plans in Earnings Call
- Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 – Issues Fiscal Year 2024 Guidance
- Merit Medical sees FY24 EPS $3.28-$3.35, consensus $3.32
- Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
- Merit Medical reports Q4 EPS 81c, consensus 76c
